Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01271465 · ClinicalTrials.gov registry record
Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant
A clinical trial of Kidney Transplantation, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT01271465 is a study of Kidney Transplantation that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants, below the 267-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01271465, a study of Kidney Transplantation, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if substances measured in a small piece of the donor organ predicts how well the organ will function in the recipient after transplant. We will be testing blood, urine, and biopsy tissue samples in this study. The research team will be looking at different risk factors in the donor organ that predict how well the kidney will do in the recipient.
Conditions Studied
Interventions
- PROCEDURE Kidney Biopsy
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-09 |
| Est. Completion | 2021-09-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01271465
The ClinicalTrials.gov registry entry for NCT01271465 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (91% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Kidney Biopsy is the first listed.
NCT01271465 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01271465 about?
NCT01271465 is a clinical study titled "Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant". The purpose of this study is to see if substances measured in a small piece of the donor organ predicts how well the organ will function in the recipient after transplant. We will be testing blood, urine, and biopsy tissue samples in this study. The research team will be looking at different risk fa...
What is the current status of trial NCT01271465?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2010-09. Estimated completion is 2021-09-18.
What conditions does trial NCT01271465 study?
This clinical trial studies the following conditions: Kidney Transplantation.
What interventions are being tested in trial NCT01271465?
The interventions under investigation include: Kidney Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01271465?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01271465 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
RECRUITING · Phase 4
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
-
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
RECRUITING · Phase 2
-
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
RECRUITING · Phase 2
-
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.